Investment House LLC Increases Holdings in SPDR S&P Biotech ETF $XBI

Investment House LLC boosted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 85.7% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 91,965 shares of the exchange traded fund’s stock after purchasing an additional 42,450 shares during the quarter. Investment House LLC’s holdings in SPDR S&P Biotech ETF were worth $9,215,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in XBI. AdvisorNet Financial Inc raised its holdings in shares of SPDR S&P Biotech ETF by 7.3% during the 3rd quarter. AdvisorNet Financial Inc now owns 1,463 shares of the exchange traded fund’s stock worth $147,000 after acquiring an additional 100 shares during the period. Sequoia Financial Advisors LLC grew its holdings in shares of SPDR S&P Biotech ETF by 3.1% in the third quarter. Sequoia Financial Advisors LLC now owns 3,393 shares of the exchange traded fund’s stock valued at $340,000 after purchasing an additional 101 shares during the period. Investment Partners Asset Management Inc. increased its position in SPDR S&P Biotech ETF by 4.0% during the second quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock worth $270,000 after purchasing an additional 125 shares during the last quarter. CWC Advisors LLC. increased its position in SPDR S&P Biotech ETF by 2.8% during the third quarter. CWC Advisors LLC. now owns 5,707 shares of the exchange traded fund’s stock worth $572,000 after purchasing an additional 157 shares during the last quarter. Finally, McAdam LLC raised its stake in SPDR S&P Biotech ETF by 5.1% during the second quarter. McAdam LLC now owns 3,273 shares of the exchange traded fund’s stock worth $271,000 after purchasing an additional 159 shares during the period.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $128.04 on Friday. The firm has a 50 day simple moving average of $122.60 and a 200-day simple moving average of $105.88. The stock has a market cap of $8.52 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $132.09.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.